Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

Article Types

Countries / Regions

Search Results (4)

Search Parameters:
Keywords = biological warfare agents (BWA)

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
13 pages, 4713 KiB  
Article
Surface Acoustic Wave Immunosensor for Detection of Botulinum Neurotoxin
by Michał Grabka, Krzysztof Jasek and Zygfryd Witkiewicz
Sensors 2023, 23(18), 7688; https://doi.org/10.3390/s23187688 - 6 Sep 2023
Cited by 7 | Viewed by 1893
Abstract
A Love-type acoustic wave sensor (AT-cut quartz substrate, SiO2 guiding layer) with a center frequency of approximately 120 MHz was used to detect a simulant of pathogenic botulinum neurotoxin type A—recombinant of BoNT-A light chain—in liquid samples. The sensor was prepared by [...] Read more.
A Love-type acoustic wave sensor (AT-cut quartz substrate, SiO2 guiding layer) with a center frequency of approximately 120 MHz was used to detect a simulant of pathogenic botulinum neurotoxin type A—recombinant of BoNT-A light chain—in liquid samples. The sensor was prepared by immobilizing monoclonal antibodies specific for botulinum neurotoxin via a thiol monolayer deposited on a gold substrate. Studies have shown that the sensor enables selective analyte detection within a few minutes. In addition, the sensor can be used several times (regeneration of the sensor is possible using a low pH buffer). Nevertheless, the detectability of the analyte is relatively low compared to other analytical techniques that can be used for rapid detection of botulinum neurotoxin. The obtained results confirm the operation of the proposed sensor and give hope for further development of this label-free technique for detecting botulinum neurotoxin. Full article
(This article belongs to the Special Issue Editorial Board Members’ Collection Series: Immunosensors)
Show Figures

Figure 1

22 pages, 394 KiB  
Review
Clinically Evaluated COVID-19 Drugs with Therapeutic Potential for Biological Warfare Agents
by Ido-David Dechtman, Ran Ankory, Keren Sokolinsky, Esther Krasner, Libby Weiss and Yoav Gal
Microorganisms 2023, 11(6), 1577; https://doi.org/10.3390/microorganisms11061577 - 14 Jun 2023
Cited by 1 | Viewed by 3639
Abstract
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak resulted in hundreds of millions of coronavirus cases, as well as millions of deaths worldwide. Coronavirus Disease 2019 (COVID-19), the disease resulting from exposure to this pathogen, is characterized, among other features, by a [...] Read more.
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak resulted in hundreds of millions of coronavirus cases, as well as millions of deaths worldwide. Coronavirus Disease 2019 (COVID-19), the disease resulting from exposure to this pathogen, is characterized, among other features, by a pulmonary pathology, which can progress to “cytokine storm”, acute respiratory distress syndrome (ARDS), respiratory failure and death. Vaccines are the unsurpassed strategy for prevention and protection against the SARS-CoV-2 infection. However, there is still an extremely high number of severely ill people from at-risk populations. This may be attributed to waning immune response, variant-induced breakthrough infections, unvaccinated population, etc. It is therefore of high importance to utilize pharmacological-based treatments, despite the progression of the global vaccination campaign. Until the approval of Paxlovid, an efficient and highly selective anti-SARS-CoV-2 drug, and the broad-spectrum antiviral agent Lagevrio, many pharmacological-based countermeasures were, and still are, being evaluated in clinical trials. Some of these are host-directed therapies (HDTs), which modulate the endogenic response against the virus, and therefore may confer efficient protection against a wide array of pathogens. These could potentially include Biological Warfare Agents (BWAs), exposure to which may lead to mass casualties due to disease severity and a possible lack of efficient treatment. In this review, we assessed the recent literature on drugs under advanced clinical evaluation for COVID-19 with broad spectrum activity, including antiviral agents and HDTs, which may be relevant for future coping with BWAs, as well as with other agents, in particular respiratory infections. Full article
(This article belongs to the Special Issue Pharmacological Interventions against Respiratory Viral Infections)
32 pages, 1367 KiB  
Review
Recent Trends in Protective Textiles against Biological Threats: A Focus on Biological Warfare Agents
by Joana C. Antunes, Inês P. Moreira, Fernanda Gomes, Fernando Cunha, Mariana Henriques and Raúl Fangueiro
Polymers 2022, 14(8), 1599; https://doi.org/10.3390/polym14081599 - 14 Apr 2022
Cited by 21 | Viewed by 6456
Abstract
The rising threats to worldwide security (affecting the military, first responders, and civilians) urge us to develop efficient and versatile technological solutions to protect human beings. Soldiers, medical personnel, firefighters, and law enforcement officers should be adequately protected, so that their exposure to [...] Read more.
The rising threats to worldwide security (affecting the military, first responders, and civilians) urge us to develop efficient and versatile technological solutions to protect human beings. Soldiers, medical personnel, firefighters, and law enforcement officers should be adequately protected, so that their exposure to biological warfare agents (BWAs) is minimized, and infectious microorganisms cannot be spread so easily. Current bioprotective military garments include multilayered fabrics integrating activated carbon as a sorptive agent and a separate filtrating layer for passive protection. However, secondary contaminants emerge following their accumulation within the carbon filler. The clothing becomes too heavy and warm to wear, not breathable even, preventing the wearer from working for extended hours. Hence, a strong need exists to select and/or create selectively permeable layered fibrous structures with bioactive agents that offer an efficient filtering capability and biocidal skills, ensuring lightweightness, comfort, and multifunctionality. This review aims to showcase the main possibilities and trends of bioprotective textiles, focusing on metal–organic frameworks (MOFs), inorganic nanoparticles (e.g., ZnO-based), and organic players such as chitosan (CS)-based small-scale particles and plant-derived compounds as bioactive agents. The textile itself should be further evaluated as the foundation for the barrier effect and in terms of comfort. The outputs of a thorough, standardized characterization should dictate the best elements for each approach. Full article
Show Figures

Figure 1

12 pages, 1817 KiB  
Article
Love-Wave Sensors Combined with Microfluidics for Fast Detection of Biological Warfare Agents
by Daniel Matatagui, José Luis Fontecha, María Jesús Fernández, Isabel Gràcia, Carles Cané, José Pedro Santos and María Carmen Horrillo
Sensors 2014, 14(7), 12658-12669; https://doi.org/10.3390/s140712658 - 15 Jul 2014
Cited by 23 | Viewed by 7105
Abstract
The following paper examines a time-efficient method for detecting biological warfare agents (BWAs). The method is based on a system of a Love-wave immunosensor combined with a microfluidic chip which detects BWA samples in a dynamic mode. In this way a continuous flow-through [...] Read more.
The following paper examines a time-efficient method for detecting biological warfare agents (BWAs). The method is based on a system of a Love-wave immunosensor combined with a microfluidic chip which detects BWA samples in a dynamic mode. In this way a continuous flow-through of the sample is created, promoting the reaction between antigen and antibody and allowing a fast detection of the BWAs. In order to prove this method, static and dynamic modes have been simulated and different concentrations of BWA simulants have been tested with two immunoreactions: phage M13 has been detected using the mouse monoclonal antibody anti-M13 (AM13), and the rabbit immunoglobulin (Rabbit IgG) has been detected using the polyclonal antibody goat anti-rabbit (GAR). Finally, different concentrations of each BWA simulants have been detected with a fast response time and a desirable level of discrimination among them has been achieved. Full article
(This article belongs to the Special Issue Chemo- and Biosensors for Security and Defense)
Show Figures

Graphical abstract

Back to TopTop